| J9271 | Injection, pembrolizumab, 1 mg | 14,400 | $40 | $619.2K |
| J0897 | Injection, denosumab, 1 mg | 7,140 | $20 | $135.7K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 830 | $90 | $76.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 360 | $100 | $36K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 380 | $80 | $30.7K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 2,780 | $10 | $22.2K |
| Q5122 | Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 220 | $80 | $18.4K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 1,500 | $10 | $15K |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 5,600 | $1 | $11.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 170 | $60 | $9.7K |